🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Newly Diagnosed

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents NCT05442216Phase 27 sites📍 Miami📍 Orlando📍 Buffalo Joshua Zeidner · Tests: Tagraxofusp, Azacitidine, Venetoclax A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites📍 Phoenix📍 La Jolla📍 Los Angeles Kura Oncology, Inc. · Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion NCT04655404EARLY Phase 121 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Larotrectinib, Larotrectinib surgical A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment NCT05708352Phase 25 sites📍 Los Angeles📍 San Francisco📍 Santa Monica Cedars-Sinai Medical Center · Tests: Keto Diet, Standard Anti-Cancer Diet Treatment of Newly Diagnosed High Risk Pediatric Acute Lymphoblastic Leukemia NCT06184009Phase 29 sites📍 Seoul📍 Seoul📍 Incheon Jae Wook Lee · Tests: ALL, High risk Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085Phase 3231 sites📍 Birmingham📍 Mobile📍 Anchorage Children's Oncology Group · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment NCT06679920NA2 sites📍 Amsterdam📍 Amsterdam Amsterdam UMC · Tests: Optical coherence tomography rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG NCT04943848Phase 13 sites📍 Orange📍 Chicago📍 Boston Ann & Robert H Lurie Children's Hospital of Chicago · Tests: rHSC-DIPGVax, Balstilimab, Zalifrelimab The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teriflunomide, Dexamethasone Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL NCT06151080Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Lenalidomide combined with G-CHOP (LO CHOP) Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients. NCT06625346n/a2 sites📍 Peshawar📍 Karachi The Searle Company Limited Pakistan · Tests: Fixed-Dose Combination of Amlodipine/Valsartan Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma NCT06419946Phase 320 sites📍 Graz📍 Innsbruck📍 Linz Vastra Gotaland Region · Tests: Temozolomide, Lomustine Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers NCT04747054Phase 326 sites📍 Avignon📍 Besançon📍 Bordeaux UNICANCER · Tests: Pembrolizumab, Loco-regional radiotherapy, Chemotherapy BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis NCT07151690Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: anti-BCMA/CD3 bispecific antibody RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL NCT06674096Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: RLC-CRCHOP Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB NCT07672405Phase 212 sites📍 Wentworth📍 Port Elizabeth📍 Soshanguve Global Alliance for TB Drug Development · Tests: sorfequiline, Pretomanid, Linezolid Chidamide, Venetoclax, and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia NCT06386302NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Chidamide, Venetoclax, azacitidine Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma NCT06569680Phase 21 site📍 Miami Izidore Lossos, MD · Tests: Mosunetuzumab CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults NCT06305910Phase 11 site📍 Minneapolis OX2 Therapeutics · Tests: Treatment with CD200AR-L A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML NCT05133882Phase 1, Phase 21 site📍 Hanzhou Sunshine Lake Pharma Co., Ltd. · Tests: Clifutinib Besylate Surveillance of Pancreatic Health After Diabetes Diagnosis NCT06803771NA31 sites📍 Sandbach📍 Maidstone📍 Leicester University Hospital Southampton NHS Foundation Trust · Tests: Avantect Pancreatic Cancer Test A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma NCT07477587Phase 184 sites📍 Springdale📍 Jacksonville📍 Margate Shanghai Henlius Biotech · Tests: HLX15-SC-Rd, US-DARZALEX FASPRO®-Rd Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. NCT07077616EARLY Phase 11 site📍 Thessaloniki Biogenea Pharmaceuticals Ltd. · Tests: Biological: personalized vaccine Based on genetic and transcriptional sequencing information, personalized peptide vacc… Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization NCT05327933NA1 site📍 Berlin Unfallkrankenhaus Berlin · Tests: Surgery plus endovascular MMA embolization, Surgery alone Real-world Study of Scemblix in the Treatment of Chronic Myeloid Leukemia in China NCT07375355n/a1 site📍 Wuhan Novartis Pharmaceuticals Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults NCT05465174Phase 220 sites📍 Birmingham📍 San Diego📍 San Francisco Sabine Mueller, MD, PhD · Tests: Tovorafenib A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant NCT05623020Phase 3180 sites📍 Daphne📍 Daphne📍 Fairhope Pfizer · Tests: Elranatamab, Daratumumab, Lenalidomide, Dexamethasone, Bortezomib Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis NCT06022939Phase 3117 sites📍 Goodyear📍 Tucson📍 Tucson SWOG Cancer Research Network · Tests: Autologous Hematopoietic Stem Cell Transplantation, Biopsy, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow… Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab NCT06287229Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Blinatumomab, Inotuzumab Ozogamicin, Hyper-CVAD, Mini-hyper-CVD A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) NCT04365036Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Toripalimab, Pegaspargase, Gemcitabine, Oxaliplatin, Definitive intensity-modulated radiotherapy (IMRT)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy